ADPT Adaptive Biotechnologies Corp
Nasdaq · SEC CIK 1478320 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $122.01M 70 sales by 11 insiders
- Filings on record
- 204 since 2021-07-01, latest 2026-09-18 20:17
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| ROBINS HARLAN S | CSO | — | $29.65M |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| LO FRANCIS | CHRO | — | $13.21M |
| PISKEL KYLE | CFO | — | $3.58M |
| NEUPERT PETER M | Dir | — | $3.14M |
| GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 298
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-18 20:17 | 2026-09-16 | ADPT | LO FRANCIS | CHRO | M - OptEx | $9.57 | +105.6K | 336.3K | +46% | +$1.01M |
| DMT | 2026-09-18 20:17 | 2026-09-16 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $28.06 | -115.4K | 220.9K | -34% | -$3.24M |
| T | 2026-09-17 18:50 | 2026-09-15 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $27.00 | -1,195 | 395.8K | -0.3% | -$32.3K |
| 2026-09-02 19:12 | 2026-08-31 | ADPT | OWEN KATEY EINTERZ | Dir | G - Gift | — | -12.5K | 66.1K | -16% | — | |
| 2026-08-28 17:50 | 2026-08-26 | ADPT | OWEN KATEY EINTERZ | Dir | S - Sale | $26.00 | -9,615 | 78.6K | -11% | -$250.0K | |
| D | 2026-08-20 17:55 | 2026-08-18 | ADPT | HERSHBERG ROBERT | Dir | M - OptEx | $6.32 | +15.0K | 77.3K | +24% | +$94.8K |
| DM | 2026-08-20 17:55 | 2026-08-18 | ADPT | HERSHBERG ROBERT | Dir | S - Sale+OE | $24.40 | -30.7K | 46.7K | -40% | -$748.2K |
| DM | 2026-08-19 20:15 | 2026-08-17+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.55 | +600.0K | 2.46M | +32% | +$3.93M |
| DM | 2026-08-19 20:15 | 2026-08-17+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $24.80 | -600.0K | 2.18M | -22% | -$14.88M |
| D | 2026-08-19 20:07 | 2026-08-17 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $6.32 | +15.0K | 255.3K | +6% | +$94.8K |
| DM | 2026-08-19 20:07 | 2026-08-17 | ADPT | NEUPERT PETER M | Dir | S - Sale+OE | $25.15 | -124.7K | 130.6K | -49% | -$3.14M |
| T | 2026-08-12 19:33 | 2026-08-10 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $25.00 | -3,000 | 397.0K | -0.8% | -$75.0K |
| T | 2026-08-03 18:26 | 2026-07-30 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $24.00 | -1,299 | 400.0K | -0.3% | -$31.2K |
| DT | 2026-07-23 19:34 | 2026-07-21 | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +284.8K | 1.30M | +28% | +$1.87M |
| DMT | 2026-07-23 19:34 | 2026-07-21 | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $21.89 | -492.4K | 812.1K | -38% | -$10.78M |
| T | 2026-07-20 19:19 | 2026-07-16 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $23.00 | -5,000 | 401.3K | -1% | -$115.0K |
| DMT | 2026-07-17 19:23 | 2026-07-15 | ADPT | LO FRANCIS | CHRO | M - OptEx | $8.91 | +105.8K | 336.5K | +46% | +$942.7K |
| DT | 2026-07-17 19:23 | 2026-07-15 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $22.59 | -105.8K | 230.7K | -31% | -$2.39M |
| MT | 2026-07-07 18:52 | 2026-07-02 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $22.01 | -386.2K | 1.02M | -27% | -$8.50M |
| DMT | 2026-07-06 19:19 | 2026-07-01+ | ADPT | LO FRANCIS | CHRO | M - OptEx | $8.75 | +75.6K | 275.6K | +38% | +$661.9K |
| DMT | 2026-07-06 19:19 | 2026-07-01+ | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $22.51 | -95.8K | 230.7K | -29% | -$2.16M |
| T | 2026-07-06 19:15 | 2026-07-01 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $22.00 | -487 | 406.3K | -0.1% | -$10.7K |
| DMT | 2026-06-30 19:25 | 2026-06-26+ | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | M - OptEx | $7.75 | +114.3K | 376.0K | +44% | +$885.6K |
| DMT | 2026-06-30 19:25 | 2026-06-26+ | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale+OE | $21.13 | -165.8K | 221.3K | -43% | -$3.50M |
| T | 2026-06-29 19:52 | 2026-06-25 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $20.50 | -5,000 | 406.8K | -1% | -$102.5K |
| DT | 2026-06-29 19:49 | 2026-06-25 | ADPT | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +52.1K | 67.7K | +333% | +$406.3K |
| DT | 2026-06-29 19:49 | 2026-06-25 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $20.18 | -52.1K | 15.6K | -77% | -$1.05M |
| MT | 2026-06-17 20:11 | 2026-06-15+ | ADPT | ROBINS HARLAN S | CSO | S - Sale | $17.41 | -106.2K | 1.41M | -7% | -$1.85M |
| T | 2026-06-15 19:13 | 2026-06-11 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $19.00 | -5,000 | 411.8K | -1% | -$95.0K |
| DMT | 2026-06-08 20:29 | 2026-06-04 | ADPT | LO FRANCIS | CHRO | M - OptEx | $8.85 | +19.5K | 290.7K | +7% | +$172.8K |
| DT | 2026-06-08 20:29 | 2026-06-04 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $17.49 | -39.7K | 250.9K | -14% | -$695.1K |
| T | 2026-06-08 20:27 | 2026-06-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $18.00 | -11.0K | 416.8K | -3% | -$198.0K |
| 2026-05-20 19:13 | 2026-05-18 | ADPT | PISKEL KYLE | CFO | S - Sale | $13.04 | -3,115 | 256.7K | -1% | -$40.6K | |
| DT | 2026-04-29 19:08 | 2026-04-27 | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +14.7K | 396.8K | +4% | +$124.4K |
| DT | 2026-04-29 19:08 | 2026-04-27 | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.23 | -19.0K | 377.8K | -5% | -$270.9K |
| DMT | 2026-04-24 18:29 | 2026-04-22+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +44.2K | 401.2K | +12% | +$373.6K |
| DMT | 2026-04-24 18:29 | 2026-04-22+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.96 | -57.2K | 382.1K | -13% | -$798.4K |
| DMT | 2026-04-21 18:07 | 2026-04-17+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $9.24 | +56.0K | 426.1K | +15% | +$517.9K |
| DMT | 2026-04-21 18:07 | 2026-04-17+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.60 | -69.1K | 395.1K | -15% | -$1.01M |
| DMT | 2026-04-16 19:36 | 2026-04-14+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +44.2K | 427.2K | +12% | +$373.6K |
| DMT | 2026-04-16 19:36 | 2026-04-14+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.45 | -57.2K | 408.2K | -12% | -$826.3K |
| DMT | 2026-04-13 19:44 | 2026-04-09+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.45 | +44.2K | 440.2K | +11% | +$329.0K |
| DMT | 2026-04-13 19:44 | 2026-04-09+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.26 | -57.2K | 421.2K | -12% | -$758.1K |
| DT | 2026-04-10 18:52 | 2026-04-08 | ADPT | LO FRANCIS | CHRO | M - OptEx | $3.99 | +2,344 | 293.7K | +0.8% | +$9,353 |
| DT | 2026-04-10 18:52 | 2026-04-08 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $15.07 | -22.6K | 271.2K | -8% | -$340.0K |
| T | 2026-04-10 18:48 | 2026-04-08 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $14.85 | -10.0K | 1.51M | -0.7% | -$148.5K |
| MT | 2026-04-08 19:51 | 2026-04-06+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $14.65 | -120.6K | 2.18M | -5% | -$1.77M |
| DMT | 2026-04-08 19:48 | 2026-04-06+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.30 | +56.0K | 465.1K | +14% | +$465.3K |
| DMT | 2026-04-08 19:48 | 2026-04-06+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.34 | -69.1K | 434.2K | -14% | -$990.5K |
| DMT | 2026-04-02 19:16 | 2026-04-01+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +29.4K | 466.3K | +7% | +$214.1K |
| DMT | 2026-04-02 19:16 | 2026-04-01+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.53 | -38.1K | 447.2K | -8% | -$553.7K |
| DM | 2026-03-31 | 2026-03-27+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.14 | -57.2K | 460.2K | -11% | -$751.3K |
| DM | 2026-03-31 | 2026-03-27+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +44.2K | 474.9K | +10% | +$321.1K |
| DM | 2026-03-26 | 2026-03-24+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.03 | -57.2K | 473.2K | -11% | -$802.2K |
| DM | 2026-03-26 | 2026-03-24+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +44.2K | 492.3K | +10% | +$321.1K |
| DM | 2026-03-23 | 2026-03-19+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.97 | +44.2K | 509.6K | +9% | +$307.7K |
| DM | 2026-03-23 | 2026-03-19+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.46 | -57.2K | 486.2K | -11% | -$769.6K |
| DM | 2026-03-18 | 2026-03-16+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.33 | -57.2K | 503.6K | -10% | -$762.2K |
| DM | 2026-03-18 | 2026-03-16+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.55 | +44.2K | 518.3K | +9% | +$289.3K |
| 2026-03-13 | 2026-03-11 | ADPT | LO FRANCIS | CHRO | S - Sale | $14.08 | -30.6K | 291.4K | -10% | -$430.7K | |
| 2026-03-13 | 2026-03-11 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $13.91 | -15.4K | 15.6K | -50% | -$214.1K | |
| 2026-03-13 | 2026-03-11 | ADPT | PISKEL KYLE | CFO | S - Sale | $13.17 | -18.7K | 259.8K | -7% | -$245.9K | |
| M | 2026-03-13 | 2026-03-11 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $13.17 | -470.3K | 1.85M | -20% | -$6.19M |
| 2026-03-13 | 2026-03-11 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $13.17 | -41.3K | 427.8K | -9% | -$544.4K | |
| DM | 2026-03-13 | 2026-03-11+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.55 | +44.2K | 535.7K | +9% | +$289.3K |
| DM | 2026-03-13 | 2026-03-11+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.21 | -179.7K | 517.7K | -26% | -$2.37M |
| 2026-03-13 | 2026-03-11 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $13.17 | -63.1K | 272.8K | -19% | -$831.1K | |
| M | 2026-03-13 | 2026-03-11 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $13.17 | -470.2K | 2.63M | -15% | -$6.19M |
| DM | 2026-03-10 | 2026-03-06+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.53 | +68.3K | 678.8K | +11% | +$582.6K |
| DM | 2026-03-10 | 2026-03-06+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.90 | -81.3K | 647.8K | -11% | -$1.21M |
| 2026-03-09 | 2026-03-05 | ADPT | LO FRANCIS | CHRO | S - Sale | $15.09 | -38.1K | 322.0K | -11% | -$574.5K | |
| M | 2026-03-06 | 2026-03-04+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +837.0K | 2.06M | +68% | $0 |
| 2026-03-06 | 2026-03-04 | ADPT | PISKEL KYLE | CFO | A - Grant | $0.00 | +61.9K | 278.5K | +29% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +15.6K | 62.3K | +33% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +15.6K | 88.3K | +22% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | RUBINSTEIN JULIE | Pres, COO | A - Grant | $0.00 | +81.2K | 656.5K | +14% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +15.6K | 31.0K | +102% | $0 | |
| M | 2026-03-06 | 2026-03-04+ | ADPT | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +837.0K | 1.28M | +188% | $0 |
| 2026-03-06 | 2026-03-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +39.1K | 335.9K | +13% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | LO FRANCIS | CHRO | A - Grant | $0.00 | +44.1K | 360.0K | +14% | $0 | |
| 2026-03-06 | 2026-03-04 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +15.6K | 240.3K | +7% | $0 | |
| M | 2026-03-06 | 2026-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +121.9K | 406.6K | +43% | $0 |
| DM | 2026-03-05 | 2026-03-03+ | ADPT | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $9.05 | +79.8K | 606.2K | +15% | +$722.0K |
| DM | 2026-03-05 | 2026-03-03+ | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $16.09 | -92.8K | 579.6K | -14% | -$1.49M |
| D | 2026-03-05 | 2026-03-03 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $15.30 | -48.0K | 15.4K | -76% | -$735.1K |
| D | 2026-03-05 | 2026-03-03 | ADPT | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $3.99 | +48.0K | 63.4K | +312% | +$191.7K |
| M | 2026-03-04 | 2026-03-02+ | ADPT | ROBINS HARLAN S | CSO | S - Sale | $16.19 | -24.2K | 1.17M | -2% | -$392.3K |
| M | 2026-03-03 | 2026-02-27+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $15.85 | -525.0K | 1.93M | -21% | -$8.32M |
| D | 2026-02-06 | 2026-02-04 | ADPT | PISKEL KYLE | CFO | S - Sale+OE | $18.46 | -2,145 | 216.6K | -1.0% | -$39.6K |
| D | 2026-02-06 | 2026-02-04 | ADPT | PISKEL KYLE | CFO | M - OptEx | $12.14 | +2,145 | 218.8K | +1.0% | +$26.0K |
| M | 2026-02-04 | 2026-02-02+ | ADPT | ROBINS HARLAN S | CSO | S - Sale | $18.68 | -42.8K | 1.19M | -3% | -$799.1K |
| 2026-02-04 | 2026-02-02 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $18.44 | -125.0K | 2.46M | -5% | -$2.30M | |
| DM | 2026-01-14 | 2026-01-12 | ADPT | LO FRANCIS | CHRO | M - OptEx | $7.71 | +79.6K | 395.6K | +25% | +$614.0K |
| D | 2026-01-14 | 2026-01-12 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $17.73 | -79.6K | 316.0K | -20% | -$1.41M |
| D | 2026-01-14 | 2026-01-12 | ADPT | PISKEL KYLE | CFO | M - OptEx | $12.14 | +4,290 | 220.9K | +2% | +$52.1K |
| D | 2026-01-14 | 2026-01-12 | ADPT | PISKEL KYLE | CFO | S - Sale+OE | $18.00 | -4,290 | 216.6K | -2% | -$77.2K |
| 2026-01-08 | 2026-01-06 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $16.44 | -10.0K | 1.22M | -0.8% | -$164.4K | |
| 2026-01-07 | 2026-01-05 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $15.59 | -125.0K | 2.58M | -5% | -$1.95M | |
| DA | 2026-01-07 | 2025-12-22 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $17.50 | -4,394 | 316.0K | -1% | -$76.9K |
| DMA | 2026-01-07 | 2025-12-22 | ADPT | LO FRANCIS | CHRO | M - OptEx | $6.06 | +4,394 | 317.1K | +1% | +$26.6K |
Purchase Sale Sale after option exercise All abbreviations